169 related articles for article (PubMed ID: 35450934)
1. COVID-19 and liver cancer: lost patients and larger tumours.
Geh D; Watson R; Sen G; French JJ; Hammond J; Turner P; Hoare T; Anderson K; McNeil M; McPherson S; Masson S; Dyson J; Donnelly M; MacDougal L; Patel P; Hudson M; Anstee QM; White S; Robinson S; Pandanaboyana S; Walker L; McCain M; Bury Y; Raman S; Burt A; Parkinson D; Haugk B; Darne A; Wadd N; Asghar S; Mariappan L; Margetts J; Stenberg B; Scott J; Littler P; Manas DM; Reeves HL
BMJ Open Gastroenterol; 2022 Apr; 9(1):. PubMed ID: 35450934
[TBL] [Abstract][Full Text] [Related]
2. Impact of the COVID-19 pandemic on patients with hepatocellular carcinoma in the West of Scotland: a cohort study.
McLaren AS; Spoor JA; Cartwright D; Naylor G; Barclay S; Priest M; Puttagunta S; Armstrong K; Ballantyne S; Stanley A; Jeffry Evans TR;
BMJ Open Gastroenterol; 2023 Nov; 10(1):. PubMed ID: 37989352
[TBL] [Abstract][Full Text] [Related]
3. Estimate of hepatocellular carcinoma incidence in patients with alcoholic cirrhosis.
Ganne-Carrié N; Chaffaut C; Bourcier V; Archambeaud I; Perarnau JM; Oberti F; Roulot D; Moreno C; Louvet A; Dao T; Moirand R; Goria O; Nguyen-Khac E; Carbonell N; Antonini T; Pol S; de Ledinghen V; Ozenne V; Henrion J; Péron JM; Tran A; Perlemuter G; Amiot X; Zarski JP; Beaugrand M; Chevret S;
J Hepatol; 2018 Dec; 69(6):1274-1283. PubMed ID: 30092234
[TBL] [Abstract][Full Text] [Related]
4. The impact of COVID-19 on the diagnosis and treatment of HCC: analysis of a nationwide registry for advanced liver diseases (REAL).
Okushin K; Tateishi R; Hirakawa S; Tachimori H; Uchino K; Nakagomi R; Yamada T; Nakatsuka T; Minami T; Sato M; Fujishiro M; Hasegawa K; Eguchi Y; Kanto T; Yoshiji H; Izumi N; Kudo M; Koike K
Sci Rep; 2024 Feb; 14(1):2826. PubMed ID: 38310156
[TBL] [Abstract][Full Text] [Related]
5. Effect of COVID-19 Pandemic on Hepatocellular Carcinoma Diagnosis: Results from a Single Turkey Center Study.
Bilican G; Özgül S; Ekmen N; Moral K; Küçük H; Dumanlı S; Abiyev A; Karakan T; Kekilli M
J Gastrointestin Liver Dis; 2023 Sep; 32(3):367-370. PubMed ID: 37774229
[TBL] [Abstract][Full Text] [Related]
6. The road to pandemic recovery: Tracking COVID-19's impact on cirrhosis care and outcomes among 111,558 Veterans.
Adejumo AC; Yakovchenko V; Morgan TR; Spoutz P; Chia L; Bajaj JS; Chang MF; Dominitz JA; Rogal SS
Hepatology; 2023 Jun; 77(6):2016-2029. PubMed ID: 36705024
[TBL] [Abstract][Full Text] [Related]
7. Effect of COVID-19 Pandemic on Hepatocellular Carcinoma Diagnosis: Results from a Tertiary Care Center in North-West Italy.
Ribaldone DG; Caviglia GP; Gaia S; Rolle E; Risso A; Campion D; Brunocilla PR; Saracco GM; Carucci P
Curr Oncol; 2022 Feb; 29(3):1422-1429. PubMed ID: 35323319
[TBL] [Abstract][Full Text] [Related]
8. Diagnostic and Therapeutic Delays in Patients With Hepatocellular Carcinoma.
Rao A; Rich NE; Marrero JA; Yopp AC; Singal AG
J Natl Compr Canc Netw; 2021 May; 19(9):1063-1071. PubMed ID: 34077908
[TBL] [Abstract][Full Text] [Related]
9. Telephone-Only Visits Preserved Hepatocellular Cancer Screening Rates in Patients with Cirrhosis Early in the COVID-19 Pandemic.
Rudnick SR; Ugwuegbu J; Soufleris SJ; Bundy R; Dharod A; Russo MW
Dig Dis Sci; 2023 May; 68(5):1791-1796. PubMed ID: 36562886
[TBL] [Abstract][Full Text] [Related]
10. Surveillance programme of cirrhotic patients for early diagnosis and treatment of hepatocellular carcinoma: a cost effectiveness analysis.
Bolondi L; Sofia S; Siringo S; Gaiani S; Casali A; Zironi G; Piscaglia F; Gramantieri L; Zanetti M; Sherman M
Gut; 2001 Feb; 48(2):251-9. PubMed ID: 11156649
[TBL] [Abstract][Full Text] [Related]
11. Surveillance improves survival of patients with hepatocellular carcinoma: a prospective population-based study.
Hong TP; Gow PJ; Fink M; Dev A; Roberts SK; Nicoll A; Lubel JS; Kronborg I; Arachchi N; Ryan M; Kemp WW; Knight V; Sundararajan V; Desmond P; Thompson AJ; Bell SJ
Med J Aust; 2018 Oct; 209(8):348-354. PubMed ID: 30309301
[TBL] [Abstract][Full Text] [Related]
12. Trends in mortality of liver cancer before and during the COVID-19 pandemic, 2017-2021.
Kim D; Manikat R; Cholankeril G; Ahmed A
Liver Int; 2023 Sep; 43(9):1865-1870. PubMed ID: 37387517
[TBL] [Abstract][Full Text] [Related]
13. Screening, Surveillance, and Management of Hepatocellular Carcinoma During the COVID-19 Pandemic: a Narrative Review.
Akbulut S; Garzali IU; Hargura AS; Aloun A; Yilmaz S
J Gastrointest Cancer; 2023 Jun; 54(2):408-419. PubMed ID: 35499649
[TBL] [Abstract][Full Text] [Related]
14. The COVID-19 Pandemic Highlights Opportunities to Improve Hepatocellular Carcinoma Screening and Diagnosis in a National Health System.
Kim NJ; Rozenberg-Ben-Dror K; Jacob DA; Berry K; Ioannou GN
Am J Gastroenterol; 2022 Apr; 117(4):678-684. PubMed ID: 35029156
[TBL] [Abstract][Full Text] [Related]
15. Application of hepatocellular carcinoma surveillance in a European setting. What can we learn from clinical practice?
Edenvik P; Davidsdottir L; Oksanen A; Isaksson B; Hultcrantz R; Stål P
Liver Int; 2015 Jul; 35(7):1862-71. PubMed ID: 25524812
[TBL] [Abstract][Full Text] [Related]
16. Effect of delays in the 2-week-wait cancer referral pathway during the COVID-19 pandemic on cancer survival in the UK: a modelling study.
Sud A; Torr B; Jones ME; Broggio J; Scott S; Loveday C; Garrett A; Gronthoud F; Nicol DL; Jhanji S; Boyce SA; Williams M; Riboli E; Muller DC; Kipps E; Larkin J; Navani N; Swanton C; Lyratzopoulos G; McFerran E; Lawler M; Houlston R; Turnbull C
Lancet Oncol; 2020 Aug; 21(8):1035-1044. PubMed ID: 32702311
[TBL] [Abstract][Full Text] [Related]
17. Diagnostic Delays for Non-melanoma Skin Cancers in Renal Transplant Recipients during the COVID-19 Pandemic: What is Hiding Behind the Mask?
Mokos M; Bašić-Jukić N
Acta Dermatovenerol Croat; 2021 Jul; 29(2):111-113. PubMed ID: 34477079
[TBL] [Abstract][Full Text] [Related]
18. Low incidence of COVID-19 in a prospective cohort of patients with liver cirrhosis and hepatocellular carcinoma treated at a tertiary medical center during the 2020 pandemic.
Fründt T; Kuballa L; Lütgehetman M; Nörz D; Arend H; Brehm TT; Schulze Zur Wiesch J; Horvatits T; Horvatits K; Huber S; Wege H; Kluwe J
PLoS One; 2021; 16(12):e0258450. PubMed ID: 34941875
[TBL] [Abstract][Full Text] [Related]
19. Incidence of hepatocellular carcinoma in outpatients with cirrhosis in Brazil: A 10-year retrospective cohort study.
Appel-da-Silva MC; Miozzo SA; Dossin IA; Tovo CV; Branco F; de Mattos AA
World J Gastroenterol; 2016 Dec; 22(46):10219-10225. PubMed ID: 28028370
[TBL] [Abstract][Full Text] [Related]
20. Models estimating risk of hepatocellular carcinoma in patients with alcohol or NAFLD-related cirrhosis for risk stratification.
Ioannou GN; Green P; Kerr KF; Berry K
J Hepatol; 2019 Sep; 71(3):523-533. PubMed ID: 31145929
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
